← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Functional Genetics, Inc.
Gaithersburg, MD
$7,242,555
Total funding
4
Grants
Funding over time
peak $2M · FY2006–12$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$7,242,555 · 4
By mechanism
R44$5,650,620 · 2
R43$1,591,935 · 2
Investigators at Functional Genetics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe$1,000,000
R44 · FY2011 · AI
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe$997,899
R44 · FY2012 · AI
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap$995,189
R44 · FY2011 · AI
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap$914,355
R44 · FY2012 · AI
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe$885,403
R44 · FY2010 · AI
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap$857,774
R44 · FY2010 · AI
Development of Therapeutic Agents Against Influenza by Targeting Host Factors$500,186
R43 · FY2007 · AI
Development of Therapeutic Agents Against Influenza by Targeting Host Factors$492,501
R43 · FY2006 · AI
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap$299,878
R43 · FY2008 · AI
Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap$299,370
R43 · FY2007 · AI